VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012

Sep 25, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-09-21

Reporting Person: Sachdev Amit (SVP, Corp Affairs & Pub Policy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-09-21	Common Stock	M	9531	$32.16	Acquired	30639	Direct
2012-09-21	Common Stock	S	9531	$59.00	Disposed	21108	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-09-21	Employee Stock Option (right to buy)	$32.16	M	9531	Disposed	2018-07-23	Common Stock (9531)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	662	Indirect

Footnotes

F1: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.

F2: Fully vested.